A Comprehensive Analysis of Allulose Production: Review and Update

Allulose production is moving fast

If you formulate with allulose, the supply picture keeps shifting. A review published in Foods (DOI: 10.3390/foods13162572) updates the field. It covers recent progress in D-allulose production. The focus is enzymatic conversion. That is where the biggest gains are happening.

Background: from GRAS to global ingredient

Allulose used to be hard to source. That changed. In 2019, the FDA recognized allulose as GRAS. China's NHC also approved it as a new food ingredient. These regulatory steps opened the door for use in a wider range of foods. But regulatory approval is not enough. Manufacturers need reliable, cost-effective production. The new review looks at how far production technology has come.

What the study did

The research team reviewed recent developments in D-allulose production. They focused on enzymatic conversion methods. Four areas stand out: immobilization technology, discovery of novel enzymes, directed evolution, and biosynthesis via metabolic pathway modification. The review does not just list methods. It weighs them for practical application. It also points to multi-enzyme cascade reactions. In one case, D-fructose was converted to D-allulose in fruit juice. Conversion reached 75%. Total yield was 60%. That is a strong result.

Key findings

The key findings center on biocatalysis. Enzyme immobilization gets attention as a way to stabilize and reuse catalysts. Novel enzyme discovery broadens the pool of catalysts. Directed evolution refines the enzymes themselves. Pathway engineering creates whole-cell systems for biosynthesis. These methods are moving allulose toward more efficient production.

Here is a snapshot of the production routes covered:

Production route	What the review covers	Reported benchmark
Enzymatic conversion	Immobilization, novel enzyme discovery, directed evolution	Focus area, no single number
Whole-cell biosynthesis	Metabolic pathway modification	Focus area, no single number
Multi-enzyme cascade	Biotransformation directly in fruit juice	75% conversion, 60% total yield

The cascade result deserves attention. Working in fruit juice means the process can handle real-world matrices. You do not necessarily need a purified sugar stream. That has cost implications for ingredient buyers.

Another point from the review: the regulatory landscape has shifted in parallel. The FDA's GRAS designation in 2019 and China's NHC approval gave producers a clear signal. When regulators open the door, investment follows. More production capacity means more supply options for food companies.

What it means for manufacturers

For formulators, the practical takeaway is simple. Allulose production is becoming more efficient. The reported 75% conversion and 60% total yield show what is possible with cascading enzymes. Those numbers matter because yield drives cost. The juice biotransformation work also matters. If enzymes work directly in fruit juice, production might happen inside existing fruit processing lines. That is an open question, not a promise. Still, the direction is clear.

Think about supply security too. The review covers multiple enzyme strategies. That gives producers options. Options reduce risk. For a buyer, that is a good reason to track these technical updates.

FAQ

Does the FDA consider allulose GRAS? Yes. In 2019, the FDA recognized allulose as GRAS. That opened up use in many food categories.

How efficient is enzymatic allulose production now? The review describes a multi-enzyme cascade that converts D-fructose to D-allulose at 75% conversion, with a 60% total yield. That is a strong result for a food-grade process.

Which production methods are covered in the review? Enzyme immobilization, novel enzyme discovery, directed evolution, and biosynthesis through metabolic pathway modification. The review also covers multi-enzyme cascade reactions in fruit juice.

The road ahead

Allulose is no longer waiting for regulatory approval or basic research. The pieces are in place. Enzymatic methods are improving. Yield numbers are climbing. The next few years will likely bring more commercial capacity, more stable pricing, and better enzyme options. For food formulators and ingredient buyers, the message is to stay close to the production science. It will shape your supply decisions sooner than you think.